Surgery pp 2197-2216 | Cite as


  • Hillary B. Boswell
  • Janet S. Rader
  • David E. Cohn


Given the anatomic proximity of the female reproductive system to other abdominal and pelvic structures, surgeons commonly find themselves faced with a decision regarding these organs. Similarly, the overlap of signs and symptoms in gynecological and surgical diseases commonly leads to the inclusion of a gynecological disease in a differential diagnosis.1 Thus, it is imperative that the surgeon has a general understanding of operative and nonoperative gynecology.


Cervical Cancer Endometrial Cancer Obstet Gynecol Ectopic Pregnancy Pelvic Inflammatory Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Curtis KM, Hillis SD, Kieke BA Jr, Brett KM, Marchbanks PA, Peterson HB. Visits to emergency departments for gynecologic disorders in the United States, 1992–1994. Obstet Gynecol 1998;91:1007–1012.PubMedGoogle Scholar
  2. 2.
    Visco AG, Del Priore G. Postmenopausal Bartholin gland enlargement: a hospital-based cancer risk assessment. Obstet Gynecol 1996;87:286–290.PubMedGoogle Scholar
  3. 3.
    Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility, 5th ed. Baltimore: Williams & Wilkins, 1994.Google Scholar
  4. 4.
    Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002;288(3):321–333.PubMedGoogle Scholar
  5. 5.
    Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 2004;291(14):1701–1712.PubMedGoogle Scholar
  6. 6.
    Warren MP. A comparative review of the risks and benefits of hormone replacement therapy regimens. Am J Obstet Gynecol 2004;190(4):1141–1167.PubMedGoogle Scholar
  7. 7.
    Beigi RH, Wiesenfeld HC. Pelvic inflammatory disease: new diagnostic criteria and treatment. Obstet Gynecol Clin N Am 2003;30(4):777–793.Google Scholar
  8. 8.
    Yeh JM, Hook EW 3rd, Goldie SJ. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis 2003;30(5):369–378.PubMedGoogle Scholar
  9. 9.
    Centers for Disease Control and Prevention. 2002 Guidelines for treatment of sexually transmitted diseases. MMWR (Morb Mortal Wkly Rep) 2002;51(RR-6]:48–51.Google Scholar
  10. 10.
    Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992;339:785–788.PubMedGoogle Scholar
  11. 11.
    Scholes D, Stergachis A, Ichikawa LE, Heidrich FE, Holmes KK, Stamm WE. Vaginal douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet Gynecol 1998;91:993–997.PubMedGoogle Scholar
  12. 12.
    Jacobson L. Differential diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol 1980;138:1006–1011.PubMedGoogle Scholar
  13. 13.
    Patten RM, Vincent LM, Wolner-Hanssen P, Thorpe E Jr. Pelvic inflammatory disease. Endovaginal sonography with laparoscopic correlation. J Ultrasound Med 1990;9:681–689.PubMedGoogle Scholar
  14. 14.
    Cacciatore B, Leminen A, Ingman-Friberg S, Ylostalo P, Paavonen J. Transvaginal sonographic findings in ambulatory patients with suspected pelvic inflammatory disease. Obstet Gynecol 1992;80:912–916.PubMedGoogle Scholar
  15. 15.
    Boardman LA, Peipert JF, Brody JM, Cooper AS, Sung J. Endovaginal sonography for the diagnosis of upper genital tract infection. Obstet Gynecol 1997;90:54–57.PubMedGoogle Scholar
  16. 16.
    Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol. 2003;188(2):598–600.Google Scholar
  17. 17.
    Perez-Medina T, Huertas MA, Bajo JM. Early ultrasound-guided transvaginal drainage of tubo-ovarian abscesses: a randomized study. Ultrasound Obstet Gynecol 1996;7:435–438.PubMedGoogle Scholar
  18. 18.
    Aboulghar MA, Mansour RT, Serour GI. Ultrasonographically guided transvaginal aspiration of tuboovarian abscesses and pyosalpinges: an optional treatment for acute pelvic inflammatory disease. Am J Obstet Gynecol 1995;172:1501–1503.PubMedGoogle Scholar
  19. 19.
    Nelson AL, Sinow RM, Renslo R, Renslo J, Atamdede F. Endovaginal ultrasonographically guided transvaginal drainage for treatment of pelvic abscesses. Am J Obstet Gynecol 1995;172:1926–1932.PubMedGoogle Scholar
  20. 20.
    Feld R, Eschelman DJ, Sagerman JE, Segal S, Hovsepian DM, Sullivan KL. Treatment of pelvic abscesses and other fluid collections: efficacy of transvaginal sonographically guided aspiration and drainage. AJR Am J Roentgenol 1994;163:1141–1145.PubMedGoogle Scholar
  21. 21.
    vanSonnenberg E, D’Agostino HB, Casola G, Goodacre BW, Sanchez RB, Taylor B. US-guided transvaginal drainage of pelvic abscesses and fluid collections. Radiology 1991;181:53–56.PubMedGoogle Scholar
  22. 22.
    Breen JL. A 21 year survey of 654 ectopic pregnancies. Am J Obstet Gynecol 1970;106:1004–1019.PubMedGoogle Scholar
  23. 23.
    Centers for Disease Control and Prevention. Advanced report of final mortality statistics. Mon Vital Stat Rep 1995;43:11–13.Google Scholar
  24. 24.
    Centers for Disease Control and Prevention. Ectopic pregnancy-United States 1990–1992. MMWR (Morb Mortal Wkly Rep) 1995;44:46–48.Google Scholar
  25. 25.
    Zane SB, Kieke BA Jr, Kendrick JS, Bruce C. Surveillance in a time of changing health care practices: estimating ectopic pregnancy incidence in the United States. Matern Child Health J 2002;6(4):227–236.PubMedGoogle Scholar
  26. 26.
    Chow WH, Daling JR, Cates W Jr, Greenberg RS. Epidemiology of ectopic pregnancy. Epidemiol Rev 1987;9:70–94.PubMedGoogle Scholar
  27. 27.
    Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of ectopic pregnancy after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med 1997;336:762–767.PubMedGoogle Scholar
  28. 28.
    Sulak, PJ. Intrauterine device practice guidelines: patient types. Contraception 1998;58(3 suppl):55S–58S.PubMedGoogle Scholar
  29. 29.
    American Society for Reproductive Medicine. Assisted Reproductive Technology in the United States: 2000 results generated from the ASRM/SART Registry. Fertil Steril 2004;81(5):1207–1215.Google Scholar
  30. 30.
    Kadar N, Bohrer M, Kemmann E, Shelden R. The discriminatory human chorionic gonadotropin zone for endovaginal sonography: a prospective, randomized study. Fertil Steril 1994;61:1016–1020.PubMedGoogle Scholar
  31. 31.
    Kadar N, Caldwell BV, Romero R. A method of screening for ectopic pregnancy and its indications. Obstet Gynecol 1981;58:162–166.PubMedGoogle Scholar
  32. 32.
    Barnhart KT, Sammel MD, Rinaudo PF, Zhou L, Hummel AC, Guo W. Symptomatic patients with an early viable intrauterine pregnancy: HCG curves redefined. Obstet Gynecol 2004;104(1):50–55.PubMedGoogle Scholar
  33. 33.
    Murphy AA, Nager CW, Wujek JJ, Kettel LM, Torp VA, Chin HG. Operative laparoscopy versus laparotomy for the management of ectopic pregnancy: a prospective trial. Fertil Steril 1992;57:1180–1185.PubMedGoogle Scholar
  34. 34.
    Vermesh M, Silva PD, Rosen GF, Stein AL, Fossum GT, Sauer MV. Management of unruptured ectopic gestation by linear salpingostomy: a prospective, randomized clinical trial of laparoscopy versus laparotomy. Obstet Gynecol 1989;73:400–404.PubMedGoogle Scholar
  35. 35.
    Lundorff P, Thorburn J, Lindblom B. Fertility outcome after conservative surgical treatment of ectopic pregnancy evaluated in a randomized trial. Fertil Steril 1992;57:998–1002.PubMedGoogle Scholar
  36. 36.
    Tulandi T, Guralnick M. Treatment of tubal ectopic pregnancy by salpingotomy with or without tubal suturing and salpingectomy. Fertil Steril 1991;55:53–55.PubMedGoogle Scholar
  37. 37.
    Korell M, Albrich W, Hepp H. Fertility after organ-preserving surgery of ectopic pregnancy: results of a multicenter study. Fertil Steril 1997;68:220–223.PubMedGoogle Scholar
  38. 38.
    Silva PD, Schaper AM, Rooney B. Reproductive outcome after 143 laparoscopic procedures for ectopic pregnancy. Obstet Gynecol 1993;81:710–715.PubMedGoogle Scholar
  39. 39.
    de la Cruz A, Cumming DC. Factors determining fertility after conservative or radical surgical treatment for ectopic pregnancy. Fertil Steril 1997;68:871–874.Google Scholar
  40. 40.
    Hajenius PJ, Engelsbel S, Mol BW, et al. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet 1997;350:774–779.PubMedGoogle Scholar
  41. 41.
    Stovall TG, Ling FW. Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol 1993;168:1759–1762.PubMedGoogle Scholar
  42. 42.
    Lipscomb GH, Bran D, McCord ML, Portera JC, Ling FW. Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexate. Am J Obstet Gynecol 1998;178:1354–1358.PubMedGoogle Scholar
  43. 43.
    Stika CS, Anderson L, Frederiksen MC. Single-dose methotrexate for the treatment of ectopic pregnancy: Northwestern Memorial Hospital three-year experience. Am J Obstet Gynecol 1996;174:1840–1846.PubMedGoogle Scholar
  44. 44.
    Glock JL, Johnson JV, Brumsted JR. Efficacy and safety of single-dose systemic methotrexate in the treatment of ectopic pregnancy. Fertil Steril 1994;62:716–721.PubMedGoogle Scholar
  45. 45.
    Alexander JM, Rouse DJ, Varner E, Austin JM Jr. Treatment of the small unruptured ectopic pregnancy: a cost analysis of methotrexate versus laparoscopy. Obstet Gynecol 1996;88:123–127.PubMedGoogle Scholar
  46. 46.
    ACOG Practice Bulletin. Medical Management of Tubal Pregnancy. Number 3, December 1998. Obstet Gynecol 1998;92(6):510–511.Google Scholar
  47. 47.
    ACOG Practice Bulletin. Prevention of Rh D Alloimmunization. Number 4, May 1999. Obstet Gynecol 1999;93(5):627–633.Google Scholar
  48. 48.
    Sommerville M, Grimes DA, Koonings PP, Campbell K. Ovarian neoplasms and the risk of adnexal torsion. Am J Obstet Gynecol 1991;164:577–578.PubMedGoogle Scholar
  49. 49.
    Merritt DF. Torsion of the uterine adnexa: a review. Adolesc Pediatr Gynecol 1991;4:3–13.Google Scholar
  50. 50.
    Chang KH, Hwang KJ, Kwon HC, et al. Conservative therapy of adnexal torsion employing color Doppler sonography. J Am Assoc Gynecol Laparosc 1998;5:13–17.PubMedGoogle Scholar
  51. 51.
    Lee EJ, Kwon HC, Joo HJ, Suh JH, Fleischer AC. Diagnosis of ovarian torsion with color Doppler sonography: depiction of twisted vascular pedicle. J Ultrasound Med 1998;17:83–89.PubMedGoogle Scholar
  52. 52.
    Fleischer AC, Stein SM, Cullinan JA, Warner MA. Color Doppler sonography of adnexal torsion. J Ultrasound Med 1995;14:523–528.PubMedGoogle Scholar
  53. 53.
    Zweizig S, Perron J, Grubb D, Mishell DR Jr. Conservative management of adnexal torsion. Am J Obstet Gynecol 1993;168:1791–1795.PubMedGoogle Scholar
  54. 54.
    Chapron C, Capella-Allouc S, Dubuisson JB. Treatment of adnexal torsion using operative laparoscopy. Hum Reprod (Oxf) 1996;11:998–1103.PubMedGoogle Scholar
  55. 55.
    McHutchinson LL, Koonings PP, Ballard CA, d’Ablaing G III. Preservation of ovarian tissue in adnexal torsion with fluorescein. Am J Obstet Gynecol 1993;168:1386–1388.PubMedGoogle Scholar
  56. 56.
    Goldstein SR, Subramanyam B, Snyder JR, Beller U, Raghavendra BN, Beckman EM. The postmenopausal cystic adnexal mass: the potential role of ultrasound in conservative management. Obstet Gynecol 1989;73:8–10.PubMedGoogle Scholar
  57. 57.
    Bailey CL, Ueland FR, Land GL, et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol 1998;69:3–7.PubMedGoogle Scholar
  58. 58.
    Yuen PM, Yu KM, Yip SK, Lau WC, Rogers MS, Chang A. A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses. Am J Obstet Gynecol 1997;177:109–114.PubMedGoogle Scholar
  59. 59.
    Canis M, Mage G, Pouly JL, Wattiez A, Manhes H, Bruhat MA. Laparoscopic diagnosis of adnexal cystic masses: a 12-year experience with long-term follow-up. Obstet Gynecol 1994;83(5 Pt 1):707–712.PubMedGoogle Scholar
  60. 60.
    Childers JM, Nasseri A, Surwit EA. Laparoscopic management of suspicious adnexal masses. Am J Obstet Gynecol 1996;175(6):1451–1457; discussion 1457–1459.PubMedGoogle Scholar
  61. 61.
    Canis M, Pouly JL, Wattiez A, Mage G, Manhes H, Bruhat MA. Laparoscopic management of adnexal masses suspicious at ultrasound. Obstet Gynecol 1997;89(5 Pt 1):679–683.PubMedGoogle Scholar
  62. 62.
    Dottino PR, Levine DA, Ripley DL, Cohen CJ. Laparoscopic management of adnexal masses in premenopausal and postmenopausal women. Obstet Gynecol 1999;93(2):223–228.PubMedGoogle Scholar
  63. 63.
    Montz FJ, Schlareth JB, Morrow CP. The natural history of theca lutein cysts. Obstet Gynecol 1988;72:247–251.PubMedGoogle Scholar
  64. 64.
    Sandenbergh HA, Woodruff JD. Histogenesis of pseudomyxoma peritonei. Review of 9 cases. Obstet Gynecol 1977;49:339–345.PubMedGoogle Scholar
  65. 65.
    Wheeler JM. Epidemiology of endometriosis-associated infertility. J Reprod Med 1989;34(1):41–46.PubMedGoogle Scholar
  66. 66.
    American Society for Reproductive Medicine. Revised classification of endometriosis: 1996. Fertil Steril 1997;67(5):817–821.Google Scholar
  67. 67.
    Koninckx PR, Martin DC. Deep endometriosis: a consequence of infiltration or retraction or possibly adenomyosis externa? Fertil Steril 1992;58(5):924–928.PubMedGoogle Scholar
  68. 68.
    Koninckx PR, Oosterlynck D, D’Hooghe T, Meuleman C. Deeply infiltrating endometriosis is a disease whereas mild endometriosis could be considered a non-disease. Ann N Y Acad Sci 1994;734:333–341.PubMedGoogle Scholar
  69. 69.
    Adamson D. Surgical management of endometriosis. Semin Reprod Med 2003;21(2):223–234.PubMedGoogle Scholar
  70. 70.
    Mol BW, Bayram N, Lijmer JG, et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 1998;70(6):1101–1108.PubMedGoogle Scholar
  71. 71.
    Colacurci N, Fortunato N, De Franciscis P, et al. Serum and peritoneal CA-125 levels as diagnostic test for endometriosis. Eur J Obstet Gynecol Reprod Biol 1996;66(1):41–43.PubMedGoogle Scholar
  72. 72.
    Ling FW. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group. Obstet Gynecol 1999;93(1):51–58.PubMedGoogle Scholar
  73. 73.
    Sutton CJG, Ewen SP, Whitelaw N, Haines P. Prospective, randomized, double-blind controls: trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild and moderate endometriosis. Fertile Steril 1994;62:696–700.Google Scholar
  74. 74.
    Jones KD, Haines P, Sutton CJG. Long-term follow-up of a controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild and moderate endometriosis. J Surg Laparosc Surg 2002;5:111–115.Google Scholar
  75. 75.
    Olive DL, Shwartz LB. Endometriosis. N Engl J Med 1993;328:1759–1769.PubMedGoogle Scholar
  76. 76.
    Ries LAG, Eisner MP, Kosary CL, et al., eds. SEER Cancer Statistics Review, 1975–2001. National Cancer Institute, Bethesda, MD:, 2004.Google Scholar
  77. 77.
    Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57(1):43–66.PubMedGoogle Scholar
  78. 78.
    Einhorn N, Sjovall K, Knapp RC, et al. Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol 1992;80:14–18.PubMedGoogle Scholar
  79. 79.
    Colombo N, Chiari S, Maggioni A, Bocciolone L, Torri V, Man-gioni C. Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol 1994;55:S47–S51.PubMedGoogle Scholar
  80. 80.
    Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975;42:101–104.PubMedGoogle Scholar
  81. 81.
    Hoskins WJ, McGuire WP, Brady MF, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974–979.PubMedGoogle Scholar
  82. 82.
    NIH Consensus Development Panel on Ovarian Cancer. Ovarian cancer: screening, treatment, andfollow-up. JAMA 1995;273:491–497.Google Scholar
  83. 83.
    Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer (Phila) 1985;56:403–412.PubMedGoogle Scholar
  84. 84.
    Ferenczy A, Gelfand M. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol 1989;160:126–131.PubMedGoogle Scholar
  85. 85.
    Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P, Gad-ducci A. An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol 1998;68:274–279.PubMedGoogle Scholar
  86. 86.
    Peters WA III, Anderson WA, Thornton WN Jr, Morley GW. The selective use of vaginal hysterectomy in the management of adenocarcinoma of the endometrium. Am J Obstet Gynecol 1983;146:285–289.PubMedGoogle Scholar
  87. 87.
    Greer BE, Cain JM, Figge DC, Shy KK, Tamimi HK. Supraumbilical upper abdominal midline incision for pelvic surgery in the morbidly obese patient. Obstet Gynecol 1990;76:471–473.PubMedGoogle Scholar
  88. 88.
    Goff BA, Rice LW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 1990;38:46–48.PubMedGoogle Scholar
  89. 89.
    Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer (Phila) 1987;60:2035–2041.PubMedGoogle Scholar
  90. 90.
    Wilson TO, Podratz KC, Gaffey TA, Malkasian GD Jr, O’Brien PC, Naessens JM. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol 1990;162:418–423.PubMedGoogle Scholar
  91. 91.
    Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 1992;16:600–610.PubMedGoogle Scholar
  92. 92.
    Society of Gynecologic Oncologists. Clinical practice guidelines: uterine corpus—endometrial cancer. Oncology 1998;12:122–126.Google Scholar
  93. 93.
    Fanning J, Evans MC, Peters AJ, Samuel M, Harmon ER, Bates JS. Adjuvant radiotherapy for stage I, grade 2 endometrial adenocarcinoma and adenoacanthoma with limited myometrial invasion. Obstet Gynecol 1987;70:920–922.PubMedGoogle Scholar
  94. 94.
    Keys HM, Roberts JA, Brunetto VL, et al; Gynecologic Oncology Group. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744–751.PubMedGoogle Scholar
  95. 95.
    Thigpen JT, Blessing J, Holmsley HD, Lia S. Phase III trial of doxorubicin versus doxorubicin plus cisplatin in advanced or recurrent endometrial carcinoma. Proc Am Soc Clin Oncol 1993;12:261.Google Scholar
  96. 96.
    Ball HG, Blessing JA, Lentz SS, Mutch DG. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1996;62:278–281.PubMedGoogle Scholar
  97. 97.
    Fleming GF, Fowler JM, Waggoner SE, et al. Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study. J Clin Oncol 2001;19:1021–1029.PubMedGoogle Scholar
  98. 98.
    Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49(1):33–64.PubMedGoogle Scholar
  99. 99.
    Solomon D, Schiffman M, Tarone R; ALTS Study Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293–299.PubMedGoogle Scholar
  100. 100.
    Benedet J, Odicono F, Maisonneuve P, et al. FIGO annual report on the results of treatment in gynaecological cancer: carcinoma of the cervix uteri. J Epidemiol Biostat 1998;3:5–34.Google Scholar
  101. 101.
    Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339–1348.PubMedGoogle Scholar
  102. 102.
    Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137–1143.PubMedGoogle Scholar
  103. 103.
    Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144–1153.PubMedGoogle Scholar
  104. 104.
    Peters WA III, Liu PY, Barrett RJ II, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606–1613.PubMedGoogle Scholar
  105. 105.
    Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154–1161.PubMedGoogle Scholar
  106. 106.
    Kozak LJ, Owings MF, Hall MJ. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13 2005;(158):1–199.Google Scholar
  107. 107.
    Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States, 1988–1990. Obstet Gynecol 1994;83:549–555.PubMedGoogle Scholar
  108. 108.
    Beinfeld MT, Bosch JL, Isaacson KB, Gazelle GS. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology 2004;230(1):207–213.PubMedGoogle Scholar
  109. 109.
    Stewart EA, Gedroyc WM, Tempany CM, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 2003;189(1):48–54.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Hillary B. Boswell
    • 1
  • Janet S. Rader
    • 2
    • 3
  • David E. Cohn
    • 4
  1. 1.The Women’s Specialists of Houston, General Obstetrics and Adult Gynecology, Pediatric and Adolescent GynecologySt. Luke’s Medical TowerHoustonUSA
  2. 2.Division of Gynecologic Oncology, Department of Obstetrics and GynecologyWashington University School of MedicineSt. LouisUSA
  3. 3.Department of GeneticsWashington University School of MedicineSt. LouisUSA
  4. 4.Divisions of Gynecologic Oncology, Departments of Obstetrics and GynecologyThe Ohio State University College of Medicine and Public HealthColumbusUSA

Personalised recommendations